Concise review: Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic
- PMID:24449458
- DOI: 10.1002/stem.1649
Concise review: Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic
Abstract
Mesenchymal stem cells (MSCs) are increasingly being used in tissue engineering and cell-based therapies in all fields ranging from orthopedic to cardiovascular medicine. Despite years of research and numerous clinical trials, MSC therapies are still very much in development and not considered mainstream treatments. The majority of approaches rely on an in vitro cell expansion phase in monolayer to produce large cell numbers prior to implantation. It is clear from the literature that this in vitro expansion phase causes dramatic changes in MSC phenotype which has very significant implications for the development of effective therapies. Previous reviews have sought to better characterize these cells in their native and in vitro environments, described known stem cell interactions within the bone marrow, and discussed the use of innovative culture systems aiming to model the bone marrow stem cell niche. The purpose of this review is to provide an update on our knowledge of MSCs in their native environment, focusing on bone marrow-derived MSCs. We provide a detailed description of the differences between naive cells and those that have been cultured in vitro and examine the effect of isolation and culture parameters on these phenotypic changes. We explore the concept of "one step" MSC therapy and discuss the potential cellular and clinical benefits. Finally, we describe recent work attempting to model the MSC bone marrow niche, with focus on both basic research and clinical applications and consider the challenges associated with these new generation culture systems.
Keywords: Bone marrow; Cell culture; Cell therapy; Cell transplantation; Mesenchymal stem cells; Stromal cells.
© 2014 AlphaMed Press.
Similar articles
- Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications.Hoch AI, Leach JK.Hoch AI, et al.Stem Cells Transl Med. 2014 May;3(5):643-52. doi: 10.5966/sctm.2013-0196. Epub 2014 Mar 28.Stem Cells Transl Med. 2014.PMID:24682286Free PMC article.Review.
- Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches.Augello A, Kurth TB, De Bari C.Augello A, et al.Eur Cell Mater. 2010 Sep 1;20:121-33. doi: 10.22203/ecm.v020a11.Eur Cell Mater. 2010.PMID:21249629Review.
- Strategies to retain properties of bone marrow-derived mesenchymal stem cells ex vivo.Zhou Y, Tsai TL, Li WJ.Zhou Y, et al.Ann N Y Acad Sci. 2017 Dec;1409(1):3-17. doi: 10.1111/nyas.13451. Epub 2017 Oct 6.Ann N Y Acad Sci. 2017.PMID:28984359Free PMC article.Review.
- Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy.Schweizer R, Waldner M, Oksuz S, Zhang W, Komatsu C, Plock JA, Gorantla VS, Solari MG, Kokai L, Marra KG, Rubin JP.Schweizer R, et al.Front Immunol. 2020 May 6;11:826. doi: 10.3389/fimmu.2020.00826. eCollection 2020.Front Immunol. 2020.PMID:32435248Free PMC article.
- Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein.Qian H, Le Blanc K, Sigvardsson M.Qian H, et al.J Biol Chem. 2012 Jul 27;287(31):25795-807. doi: 10.1074/jbc.M112.339622. Epub 2012 May 31.J Biol Chem. 2012.PMID:22654106Free PMC article.
Cited by
- MiR-34a suppression targets Nampt to ameliorate bone marrow mesenchymal stem cell senescence by regulating NAD+-Sirt1 pathway.Pi C, Ma C, Wang H, Sun H, Yu X, Gao X, Yang Y, Sun Y, Zhang H, Shi Y, Li Y, Li Y, He X.Pi C, et al.Stem Cell Res Ther. 2021 May 6;12(1):271. doi: 10.1186/s13287-021-02339-0.Stem Cell Res Ther. 2021.PMID:33957971Free PMC article.
- The role of CCN family genes in haematological malignancies.Wells JE, Howlett M, Cheung LC, Kees UR.Wells JE, et al.J Cell Commun Signal. 2015 Sep;9(3):267-78. doi: 10.1007/s12079-015-0296-4. Epub 2015 May 31.J Cell Commun Signal. 2015.PMID:26026820Free PMC article.
- Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives.Ho-Shui-Ling A, Bolander J, Rustom LE, Johnson AW, Luyten FP, Picart C.Ho-Shui-Ling A, et al.Biomaterials. 2018 Oct;180:143-162. doi: 10.1016/j.biomaterials.2018.07.017. Epub 2018 Jul 11.Biomaterials. 2018.PMID:30036727Free PMC article.Review.
- Cellular expansion of MSCs: Shifting the regenerative potential.Miclau K, Hambright WS, Huard J, Stoddart MJ, Bahney CS.Miclau K, et al.Aging Cell. 2023 Jan;22(1):e13759. doi: 10.1111/acel.13759. Epub 2022 Dec 19.Aging Cell. 2023.PMID:36536521Free PMC article.Review.
- Bone marrow-derived stem/stromal cells (BMSC) 3D microtissues cultured in BMP-2 supplemented osteogenic induction medium are prone to adipogenesis.Futrega K, Mosaad E, Chambers K, Lott WB, Clements J, Doran MR.Futrega K, et al.Cell Tissue Res. 2018 Dec;374(3):541-553. doi: 10.1007/s00441-018-2894-y. Epub 2018 Aug 22.Cell Tissue Res. 2018.PMID:30136155Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources